(Q37549888)

21 August 2017

1 reference

title

Hematopoietic stem cell transplantation for pediatric autoimmune disease: where we stand and where we need to go. (English)

1 reference

stem cell transplantation

21 August 2017

1 reference

1 reference

A C Krauss

1

1 reference

21 August 2017

N R Kamani

series ordinal

2

1 reference

21 August 2017

language of work or name

English

0 references

publication date

13 July 2009

1 reference

Bone Marrow Transplantation

21 August 2017

1 reference

21 August 2017

44

1 reference

21 August 2017

3

1 reference

21 August 2017

137-143

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2009.147

21 August 2017

0 references

cites work

Network in pediatric rheumatology: the example of the Pediatric Rheumatology International Trials Organization

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Current management of juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Clearance of severe psoriasis after allogenic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Haematopoietic SCT in autoimmune diseases in children: rationale and new perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Bone Marrow Transplantation in Patients with Gold-Induced Marrow Aplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Non-myeloablative stem cell transplantation for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Resetting the adaptive immune system after autologous stem cell transplantation: lessons from responses to vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Transmission of type 1 diabetes by bone marrow transplantation: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Passive donor-to-recipient transfer of antiphospholipid syndrome following allogeneic stem-cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Expression of genetically determined diabetes and insulitis in the nonobese diabetic (NOD) mouse at the level of bone marrow-derived cells. Transfer of diabetes and insulitis to nondiabetic (NOD X B10) F1 mice with bone marrow cells from NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Induction of graft-versus-autoimmune (GVA) disease effect against refractory psoriasis by complete donor-type chimerism and graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

The origins of the identification and isolation of hematopoietic stem cells, and their capability to induce donor-specific transplantation tolerance and treat autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Haematopoietic stem cell gene therapy to treat autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Transplantation of autoimmune potential. I. Development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand Black mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Rationale for bone marrow transplantation in the treatment of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Treatment of severe autoimmune disease by stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Intra-bone marrow-bone marrow transplantation: a new strategy for treatment of stem cell disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Autologous hematopoietic stem cell transplantation for 3 patients with severe juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Use of CD34+ autologous stem cell transplantation in the treatment of children with refractory systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Correction of celiac disease after allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Disappearance of diffuse calcinosis following autologous stem cell transplantation in a child with autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Treatment of the Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome (IPEX) by Allogeneic Bone Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Autologous stem cell transplantation for systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Haematopoetic stem cell transplantation for refractory autoimmune cytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Allogeneic bone marrow transplantation: cure for familial Mediterranean fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Comparative outcome of hematopoietic stem cell transplantation for pediatric acute lymphoblastic leukemia following cyclophosphamide and total body irradiation or VP16 and total body irradiation conditioning regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Update on biologics in juvenile idiopathic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Prognosis in children with rheumatic diseases: justification for consideration of new therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

A new case of IPEX receiving bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

Juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Stem cell transplantation for autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Transfer of autoimmune hypothyroidism following bone marrow transplantation from a donor with Graves' disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Adoptive autoimmune hyperthyroidism following allogeneic stem cell transplantation from an HLA-identical sibling with Graves' disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Celiac disease transmitted by allogeneic non-T cell-depleted bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Tweaking the immune system: gene therapy-assisted autologous haematopoietic stem cell transplantation as a treatment for autoimmune disease.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Stem cell transplantation for autoimmune diseases: what can we learn from experimental models?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Transplantation of bone marrow transduced to express self-antigen establishes deletional tolerance and permanently remits autoimmune disease

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Hemophagocytosis during fludarabine-based SCT for systemic juvenile idiopathic arthritis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Autologous hematopoietic stem cell transplantation for autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Nonmyeloablative allogeneic bone marrow transplantation of a child with systemic autoimmune disease and lung vasculitis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Autologous stem cell transplantation for systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Resolution of immune haemolytic anaemia with allogeneic bone marrow transplantation after an unsuccessful autograft

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Comparison of renal disease severity and outcome in patients with primary antiphospholipid syndrome, antiphospholipid syndrome secondary to systemic lupus erythematosus (SLE) and SLE alone

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2009.147

7 January 2021

Identifiers

DOI

10.1038/BMT.2009.147

1 reference

Dimensions Publication ID

21 August 2017

0 references

1 reference